|
NAA50 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.47749995255731E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.3533996146009E-10 |
| Normal-vs-Stage2 |
1.807060E-04 |
| Normal-vs-Stage3 |
1.433800E-02 |
| Normal-vs-Stage4 |
3.546300E-02 |
| Stage1-vs-Stage2 |
4.414800E-01 |
| Stage1-vs-Stage3 |
2.643900E-02 |
| Stage1-vs-Stage4 |
5.887200E-01 |
| Stage2-vs-Stage3 |
3.593000E-01 |
| Stage2-vs-Stage4 |
9.854200E-01 |
| Stage3-vs-Stage4 |
4.841200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.27909999153775E-09 |
| Normal-vs-AfricanAmerican |
6.97830000007116E-07 |
| Normal-vs-Asian |
2.411700E-02 |
| Caucasian-vs-AfricanAmerican |
6.866400E-01 |
| Caucasian-vs-Asian |
6.743400E-01 |
| AfricanAmerican-vs-Asian |
7.580600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.78289638397678E-11 |
| Normal-vs-Female |
4.297900E-02 |
| Male-vs-Female |
2.32719999999631E-05 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.52920999999528E-05 |
| Normal-vs-Extreme_Weight |
3.44809736319007E-11 |
| Normal-vs-Obese |
1.08990000002862E-06 |
| Normal-vs-Extreme_Obese |
5.183200E-03 |
| Normal_Weight-vs-Extreme_Weight |
1.604380E-01 |
| Normal_Weight-vs-Obese |
6.672800E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.683400E-01 |
| Extreme_Weight-vs-Obese |
2.028300E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.484000E-01 |
| Obese-vs-Extreme_Obese |
3.614800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.188600E-01 |
| Normal-vs-Age(41-60Yrs) |
1.67120000060805E-08 |
| Normal-vs-Age(61-80Yrs) |
4.12110001679622E-09 |
| Normal-vs-Age(81-100Yrs) |
2.06960000026513E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.178300E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.631900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.678110E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.745800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.876580E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.598820E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.71049882328134E-11 |
| Normal-VS-Type2 PRCC |
1.80430000051857E-07 |
| Normal-VS-KIRP CIMP |
2.393800E-01 |
| Normal-VS-Unclassified PRCC |
1.771900E-04 |
| Type1 PRCC-VS-Type2 PRCC |
1.802170E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.08050000002802E-06 |
| Type1 PRCC-VS-Unclassified PRCC |
2.055800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.18559999999713E-05 |
| Type2 PRCC-VS-Unclassified PRCC |
8.088200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.120410E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.28600027796233E-10 |
| Normal-vs-N1 |
5.278200E-01 |
| Normal-vs-N2 |
4.704400E-01 |
| N0-vs-N1 |
3.240000E-03 |
| N0-vs-N2 |
6.315000E-01 |
| N1-vs-N2 |
5.103000E-01 |
|
|
